High Content Analysis of Cardiac Differentiation from iPS Cells
22 Jun 2011

In this application note, Molecular Devices use iPS-derived cardiomyocytes as a model system for testing toxicity and cardioprotection effects of drug candidates. High content imaging methods are described that allow automatic evaluation of differentiation of iPS derived cardiomyocytes. The model system is used to determine IC50s of several cardiotoxic drugs (doxozamine, imatinib, mitomycinA, verapamil). In addition, the cytoprotection effect of sphingosine phosphate against cytotoxic damage is analysed.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!